Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission

Xavier Poire*, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Patrice Chevallier, Johan Maertens, Eric Deconinck, Edouard Forcade, Alessandro Rambaldi, Gabriela M. Baerlocher, Tsila Zuckerman, Liisa Volin, Harry C. Schouten, Norbert Ifrah, Mohamad Mohty, Jordi Esteve, Arnon Nagler

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)231-239
Number of pages9
JournalAmerican Journal of Hematology
Volume94
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • BONE-MARROW-TRANSPLANTATION
  • ACUTE MYELOCYTIC-LEUKEMIA
  • MINIMAL RESIDUAL DISEASE
  • NO-DONOR ANALYSIS
  • WORKING PARTY
  • INTENSIVE CHEMOTHERAPY
  • EUROPEAN-SOCIETY
  • AML PATIENTS
  • MUTATIONS
  • BLOOD

Cite this

Poire, X., Labopin, M., Polge, E., Blaise, D., Chevallier, P., Maertens, J., Deconinck, E., Forcade, E., Rambaldi, A., Baerlocher, G. M., Zuckerman, T., Volin, L., Schouten, H. C., Ifrah, N., Mohty, M., Esteve, J., & Nagler, A. (2019). Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American Journal of Hematology, 94(2), 231-239. https://doi.org/10.1002/ajh.25355